8017740

Source:http://linkedlifedata.com/resource/pubmed/id/8017740

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036043, umls-concept:C0149871, umls-concept:C0206460, umls-concept:C0392806, umls-concept:C0543467, umls-concept:C1521808
pubmed:issue	2
pubmed:dateCreated	1994-7-28
pubmed:abstractText	To determine the most effective and safe dose of enoxaparin to prevent deep venous thrombosis in high-risk surgical patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Enoxaparin
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0003-4819
pubmed:author	pubmed-author:BlasierR BRB, pubmed-author:ChristieM JMJ, pubmed-author:JohnsonG JGJ, pubmed-author:LyonsR MRM, pubmed-author:MacFarlaneD EDE, pubmed-author:SpiroT ETE, pubmed-author:TremaineM DMD
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	121
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	81-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:8017740-Aged, pubmed-meshheading:8017740-Double-Blind Method, pubmed-meshheading:8017740-Drug Administration Schedule, pubmed-meshheading:8017740-Enoxaparin, pubmed-meshheading:8017740-Female, pubmed-meshheading:8017740-Hip Prosthesis, pubmed-meshheading:8017740-Humans, pubmed-meshheading:8017740-Injections, Subcutaneous, pubmed-meshheading:8017740-Male, pubmed-meshheading:8017740-Middle Aged, pubmed-meshheading:8017740-Thrombophlebitis, pubmed-meshheading:8017740-Treatment Outcome
pubmed:year	1994
pubmed:articleTitle	Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
pubmed:affiliation	Rhône-Poulenc Rorer Pharmaceuticals, Collegeville, Pennsylvania.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study